2024–2025 Recommendations for Influenza Prevention and Treatment in Children: An Update for Pediatric Providers

Registration is not required.

Date: Thursday, November 14, 2024

Time: 2:00 PM – 3:00 PM ET  

A few minutes before the webinar begins, please click the link below to join:

https://www.zoomgov.com/j/1601317466

Webinar ID: 160 131 7466

Passcode: 701844

Telephone:
+1 646 828 7666

One-tap mobile:
+16468287666,,1601317466#,,,,*701844#

International Numbers

COCA Call Objectives

Activity-Specific Objectives

1. Highlight key recommendations in the AAP influenza policy statement, “Recommendations for Prevention and Control of Influenza in Children, 2024-2025” and in the CDC Advisory Committee on Immunization Practices’ document, “Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2024-2025 Influenza Season.”
2. Review strategies pediatric healthcare providers may implement to increase influenza vaccination rates and highlight current health disparities in vaccination coverage.
3. Describe considerations and best practices for co-administering influenza vaccines and other childhood immunizations.
4. List recommendations for influenza testing in outpatient and hospitalized pediatric patients with suspected influenza and describe test limitations.
5. Review antiviral medications for influenza and CDC recommendations for antiviral treatment of children with suspected or lab-confirmed influenza.

To be posted. Please check back

ACCREDITATION STATEMENTS

In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME:  The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA CME: Credit Designation Statement – Live
The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

CNE: The Centers for Disease Control and Prevention designates this activity for 1 nursing contact hours.

CPE: The Centers for Disease Control and Prevention designated this Knowledge-based event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is JA4008229-0000-24-058-L04-P and enduring JA4008229-0000-24-059-H04-P.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEUs for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES^®) and/or Master Certified Health Education Specialists (MCHES^®) to receive up to 1 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1. Continuing Competency credits available are 1. CDC provider number 98614.

AAVSB/RACE: This program has been submitted (but not yet approved) for 1 hours of continuing education credit in jurisdictions which recognize AAVSB RACE approval; however, participants should be aware that some boards have limitations on the number of hours accepted in certain categories or restrictions on certain methods of delivery of continuing education.

For Certified Public Health Professionals (CPH): The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credits for this program.

DISCLOSURE: In compliance with continuing education requirements, all planners and presenters/moderators must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.

CDC, our planners, and presenters/moderators wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients with the exception of Dr. Kristina Bryant who would like to disclose that she is an investigator on multicenter vaccine trials with Enanta, receives an honoraria for a column in Pediatrics News, and receives royalties from Oxford University Press. All of the relevant financial relationships listed for this individual have been mitigated.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Kristina Bryant’s discussion about the American Academy of Pediatrics (AAP) recommendation that the use of HD influenza vaccine could be considered in children aged 3–17 years who have undergone hematopoietic cell transplantation.

CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.

Instructions for Obtaining Continuing Education (CE)

To receive continuing education (CE) for WC4520R-111424—2024–2025 Recommendations for Influenza Prevention and Treatment in Children: An Update for Pediatric Providers, please visit CDC TRAIN and search for the course in the Course Catalog using WC4520R-111424. Follow the steps below by December 16, 2024. The registration code is COCA111424.

To receive continuing education (CE) for WD4520R-111424—2024–2025 Recommendations for Influenza Prevention and Treatment in Children: An Update for Pediatric Providers, please visit CDC TRAIN and search for the course in the Course Catalog using WD4520R-111424. Follow the steps below between December 17, 2024, and December 17, 2026.

1. Register for and complete the course.
2. Pass the post-assessment at 75%.
3. Complete the evaluation.
4. Visit Your Learning to access your certificates and transcript.

FEES: There are no fees for CE.

• Physicians
• Nurses
• Pharmacists
• Veterinarians
• Physician Assistants
• Health Educators
• Other Clinicians

System requirements to use Zoomexternal icon

• Contact Information: coca@cdc.gov
• Support/Funding: Centers for Disease Control and Prevention, Office of Emergency Risk Communication
• Method of Participation: You may participate in the educational activity by viewing the program information above.